期刊文献+

齐拉西酮与利培酮治疗精神分裂症对照观察

Effect of ziprasidone and risperidone in the treatment of schizophrenia
下载PDF
导出
摘要 目的探讨齐拉西酮与利培酮相比治疗精神分裂症的临床疗效及安全性。方法将100例精神分裂症患者随机分两组,观察组采用齐拉西酮治疗,对照组采用利培酮治疗。治疗8周后用简明精神病评定量表(BPRS)、阳性症状量表(SAPS)、阴性症状量表(SANS)进行疗效评定。结果 3个量表组内比较时,两组治疗后2、4、8周与治疗前比较,差异均有统计学意义(P<0.05)。各项评定时间组间比较时,两组差异无统计学意义(P>0.05)。观察组疗效优于对照组,两组不良反应有差异。结论齐拉西酮是一种较理想的治疗精神分裂症的药物,其疗效确切,安全性较好,值得临床推广应用。 Objective To explore the clinical curative effect and security of ziprasidone and risperidone in the treatment of schizophrenia.Methods 100 cases were divided into two groups randomly,as ziprasidone group(the observation group)and risperidone group(the control group).The clinical effect was assessed with BPRS,ASPS and SANS after 8 weeks.Results The effective rate of the observation group was better than the control group,the difference between the two groups wasn't significant(P0.05).The two groups after the treatment of 2,4,8 and before treatment,the difference was statistically.Conclusion Ziprasidone is a better drugs for the treatment of schizophrenia for its good efficacy and safety.
出处 《中国现代医药杂志》 2011年第6期70-72,共3页 Modern Medicine Journal of China
关键词 精神分裂症 齐拉西酮 利培酮 Schizophrenia Ziprasidone Risperidone
  • 相关文献

参考文献7

  • 1李小莲,陆小兵,郑胜云.奥氮平与齐拉西酮治疗精神分裂症的对照研究[J].精神医学杂志,2007,20(3):157-158. 被引量:36
  • 2张明同.精神科评定量表手册[M].长沙:湖南科学技术出版社,1998:17,133,121,150.
  • 3中华医学会精神科分会.中国精神疾病分类及诊断标准[M].3版.济南:山东科学技术出版社,2001:75-78.
  • 4Goff DC, Posever T, Herzl,et al.An exploratory haloperidol control finding study zip in hospitalized patients with schizophrenia or sehizo affetive disorder[J].J Clin Psyehophamrmacol, 1998,18 (4) : 296.
  • 5潘桂花,李华芳.新型抗精神病药——齐哌西酮[J].中国新药与临床杂志,2003,22(12):746-750. 被引量:37
  • 6Harvey PD, Bowie CR.Ziprasidone : efficacy, tolerabicity, and emerging data on wider anging effectiveness [J].Expea Opin pharmacother, 2005,6(2) : 337-339.
  • 7张传芝,卢世臣,李绍敏,刘朝军,于兴旺,靳士立.齐拉西酮治疗首发精神分裂症对照研究[J].临床精神医学杂志,2007,17(5):317-318. 被引量:40

二级参考文献22

  • 1童建明,杨正春.几种新型抗精神病药介绍[J].临床精神医学杂志,2005,15(3):182-182. 被引量:147
  • 2[3]Aranitis LA,Miller BG,the Serroquel Trial 13 study group.Mutiple fixed dose of Olanzapine in patient with acute exacerbation of schizophrenia:a comparison with Haloperidol and placebo[J].Biol Psychiatry,1997,42:233~246
  • 3[6]Tonmoysharm A.Cognitive effects of conventional and atypical antipsychotics in schizophrenia[J].Br J Psychiatry,1999,174(Suppl):44~51
  • 4Broon S.Intramuscular ziprasidone:moving beyond the conventional in the trealment of acute agitation in schizophrenia[J].J Clin Psychiatry,2003,64(Suppl 19):13-18.
  • 5Miceli JJ,Anziano RJ,Robarge L,et al.The effect of carbamazepine on the stead-state pharmacokinetics of ziprasidone in healthe volunteeres[J].Br J Clin Pharmacol,2000,49(Suppl 1):65-70.
  • 6Meltzer HY.The importance of seronin-dopamine interaction in the action of clozpine[J].Br J Psychiaty,1992,160(Suppl 17):22.
  • 7Harvey PD,Bowie CR.Ziprasidone:efficacy,tolerability,and emerging data on wide-ranging effectivness[J].Expert Opin Pharmacother,2005,6:337.
  • 8Keck PE;Reeves KR;Harrigan EP.Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double- blind placebo-controlled,multicenter studies[J],2001(01).
  • 9SEEGER TF;SEYMOUR PA;SCHMIDT AW.Ziprasidone (CP-88,059):a new antipsychotic with combined dopamine and serotonin receptor antagonist activity,1995(01).
  • 10Everson G;LASSETER KC;ANDERSON KE.The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function[J],1997.

共引文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部